트리알릴 이소시아누르산염

Triallyl isocyanurate is a white crystalline solid. (NTP, 1992)

Liquid; Other Solid; Large Crystals

Melting point = 20.5 deg C; [ChemIDplus] White solid; mp = 23-25 deg C; [CAMEO] Colorless viscous liquid; [Aldrich MSDS]

This chemical does not meet GHS hazard criteria for 2.4% (10 of 419) of reports.

Warning

H302+H312 (35.8%): Harmful if swallowed or in contact with skin [Warning Acute toxicity, oral; acute toxicity, dermal]

P260, P264, P270, P273, P280, P301+P317, P302+P352, P317, P319, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 419 reports by companies from 17 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

Chemical: 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tri-2-propenyl-

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tri-2-propen-1-yl- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tri-2-propen-1-yl- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: 1,3,5-triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione (EC: 213-834-7)

1,3,5-Triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione: Does not have an individual approval but may be used under an appropriate group standard

Increased liver weights and increased liver enzymes (AST, ALT, and LDH) observed in male rats in 28-day oral study at 50 mg/kg/day; Histopathological liver changes observed at the lowest tested dose of 5 mg/kg/day; No evidence of mutagenicity; [JECDB] Causes changes in liver, bladder, and spleen weights in 14-day intermittent oral studies of rats; [RTECS] May cause irritation; Harmful by ingestion; [Aldrich MSDS] See 1,3,5-Tris(2-hydroxyethyl) isocyanurate.

Rubber Product Manufacturing

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tri-2-propen-1-yl-: ACTIVE